---
layout: splash
title: 케어젠 (214370)
excerpt: 케어젠의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
keywords: 케어젠, 214370
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 16,890 | <span style="color: cornflowerblue">-6.2<small>%</small></span> | Q:제약 | 20.8 | 3.6 | 3.8<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 성장인자, 바이오미메틱펩타이드 기반 안면, 두피, 바디 코스메슈티컬 제품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2015년 11월 17일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 정용지 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://caregen.co.kr](http://caregen.co.kr){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 09&#x2011;04 | | [임원ㆍ주요주주특정증권등소유상황보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240904000012){:target="_blank"} |
| 09&#x2011;02 | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240902000096){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![214370](/stock/images/214370.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 16,890 | <span style="color: cornflowerblue">-6.2<small>%</small></span> | <span style="color: tomato">1.1<small>%</small></span> | <span style="color: tomato">0.1<small>%</small></span> | <span style="color: cornflowerblue">-30.2<small>%</small></span> | <span style="color: cornflowerblue">-35.5<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: cornflowerblue">-59.1<small>%</small></span> | 63.0<small>%</small> | -0.94 | -64.4<small>%</small> | -42.1<small>%</small> | 0.9 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 20.8 | 3.6 | 3.8<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/214370/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=214370){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A214370&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=214370){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/214370){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/214370/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![214370](/stock/images/214370_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | -59.1<small>%</small> | 63.0<small>%</small> | -0.94 | -64.4<small>%</small> | -42.1<small>%</small> |
| 적립식[^fn_tech_metric_dca] | -29.4<small>%</small> | 62.3<small>%</small> | -0.47 | -40.1<small>%</small> | -17.9<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -2.6<small>%</small> | 43.5<small>%</small> | -0.06 | -26.2<small>%</small> | -13.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -51.8<small>%</small> | 42.6<small>%</small> | -1.22 | -55.5<small>%</small> | -32.0<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -53.0<small>%</small> | 35.2<small>%</small> | -1.50 | -55.2<small>%</small> | -27.6<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -43.2<small>%</small> | 28.0<small>%</small> | -1.54 | -43.3<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -45.3<small>%</small> | 22.6<small>%</small> | -2.00 | -45.4<small>%</small> | -17.8<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -24.0<small>%</small> | 20.6<small>%</small> | -1.16 | -27.5<small>%</small> | -25.8<small>%</small> |
| MACD[^fn_tech_metric_macd] | -30.7<small>%</small> | 39.0<small>%</small> | -0.79 | -39.5<small>%</small> | -18.7<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![214370](/stock/images/214370_corr.png){: .align-center}

|       | [윤성에프앤씨](/372170/) | [엘앤씨바이오](/290650/) | [천보](/278280/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [SK이노베이션](/096770/) | [성일하이텍](/365340/) | [에코프로](/086520/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![214370](/stock/images/214370_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}